Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells.

Zhang, Lei; Ye, Biwei; Lin, Yunfeng; Li, Yi-Dong; Wang, Jing-Quan; Chen, Zhuo; Ping, Feng-Feng; Chen, Zhe-Sheng.

Afiliação

Zhang L; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
Ye B; State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, China.
Lin Y; University of Chinese Academy of Sciences, Beijing, China.
Li YD; State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, China.
Wang JQ; Fujian Agriculture and Forestry University, Fuzhou, China.
Chen Z; State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, China.
Ping FF; Fujian Agriculture and Forestry University, Fuzhou, China.
Chen ZS; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.

Front Pharmacol ; 13: 867128, 2022.

Article em En | MEDLINE | ID: mdl-35450042